论文标题

突变引起的感染波在诸如COVID-19的疾病中

Mutation induced infection waves in diseases like COVID-19

论文作者

Schwarzendahl, Fabian Jan, Grauer, Jens, Liebchen, Benno, Löwen, Hartmut

论文摘要

在全球超过600万人死亡之后,征服Covid-19疾病的持续疫苗接种现在正在与日益传染性突变的出现竞争,反复弥补早期菌株。在类似情况下传染病的长期演变的历史例子几乎不存在,模型对于可能场景至关重要。因此,在目前的工作中,我们系统地将流行的易感性感染的模型概括为解释突变导致反复发生的新菌株,我们基于从统计力学的工具中粗略地谷物来得出一个预测最可能结果的模型。该模型预测,突变会在早期诱导感染数量的超指数生长,这会自我扩大至巨大的感染波,这是由于感染数量和突变之间的正反馈回路引起的,并导致大多数人群的同时感染。在稍后的阶段 - 如果疫苗接种的进展太慢 - 突变可能会中断感染数量的持续减少,并可能引起感染复兴,这些复兴是单波或什至是整个波列的替代性降低和增加感染数量的替代时期。应在更详细的模型中测试这种可能突变引起的情景的全景,以探讨其对特定传染病的具体意义。此外,我们的结果可能对于讨论释放疫苗可能性的重要性,以减少突变引起的感染复兴的风险的重要性,同时也可以协调感染数量下降趋势后的措施释放。

After more than 6 million deaths worldwide, the ongoing vaccination to conquer the COVID-19 disease is now competing with the emergence of increasingly contagious mutations, repeatedly supplanting earlier strains. Following the near-absence of historical examples of the long-time evolution of infectious diseases under similar circumstances, models are crucial to exemplify possible scenarios. Accordingly, in the present work we systematically generalize the popular susceptible-infected-recovered model to account for mutations leading to repeatedly occurring new strains, which we coarse grain based on tools from statistical mechanics to derive a model predicting the most likely outcomes. The model predicts that mutations can induce a super-exponential growth of infection numbers at early times, which self-amplify to giant infection waves which are caused by a positive feedback loop between infection numbers and mutations and lead to a simultaneous infection of the majority of the population. At later stage -- if vaccination progresses too slowly -- mutations can interrupt an ongoing decrease of infection numbers and can cause infection revivals which occur as single waves or even as whole wave trains featuring alternative periods of decreasing and increasing infection numbers. This panorama of possible mutation-induced scenarios should be tested in more detailed models to explore their concrete significance for specific infectious diseases. Further, our results might be useful for discussions regarding the importance of a release of vaccine-patents to reduce the risk of mutation-induced infection revivals but also to coordinate the release of measures following a downwards trend of infection numbers.

扫码加入交流群

加入微信交流群

微信交流群二维码

扫码加入学术交流群,获取更多资源